Technology area: Medical Devices & Mechanical Engineering
4 pending office actions • 2 art units • 3 examiners • 0 of 4 (0%) have an AI response strategy ready
Corentec Co. Ltd. has 4 pending office actions in the Medical Devices & Mechanical Engineering technology area. These actions are distributed among 3 distinct examiners and 2 distinct art units. This distribution indicates that the company's prosecution effort is spread across multiple points of review, requiring the management of interactions with several patent office groups. The presence of 4 pending actions suggests an active filing strategy within the medical device sector, as the company is engaging with 3 distinct examiners simultaneously.
ADRIAN FLORES is the busiest examiner for the company, handling 2 pending office actions. With the remaining workload split among other officials, the company must balance a primary relationship with one examiner while also addressing the requirements of the other examiners involved in its medical device applications. This multi-examiner landscape requires a prosecution strategy that can adapt to different examination styles. For a practitioner, the current workload requires coordination across 2 distinct art units to ensure consistency in the company's patent claims.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 4 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FLORES, ADRIAN | 2 | 100.0% | +0.0% |
| SIPP, AMY R. | 1 | 71.1% | +25.6% |
| SHARMA, YASHITA | 1 | 81.8% | +24.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18688599 | Acetabular Cup Impactor, Anteversion Guide, and Surgical Instrument | SIPP, AMY R. | 36d overdue |
| 18251769 | Modular Augment | SHARMA, YASHITA | 25d overdue |
| 18706319 | Glenoid Baseplate | FLORES, ADRIAN | — |
| 18706309 | Glenoid Baseplate | FLORES, ADRIAN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18688599 | Acetabular Cup Impactor, Anteversion Guide, and Surgical Instrument | SIPP, AMY R. | 36d overdue |
| 18251769 | Modular Augment | SHARMA, YASHITA | 25d overdue |
| Art Unit | Apps |
|---|---|
| 3775 | 1 |
| 3774 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18706319 | Glenoid Baseplate | FLORES, ADRIAN | — | §102§103 | Non-Final OA | — | Pending | Apr 30, 2024 |
| 18706309 | Glenoid Baseplate | FLORES, ADRIAN | — | §102§103 | Non-Final OA | — | Pending | Apr 30, 2024 |
| 18688599 | Acetabular Cup Impactor, Anteversion Guide, and Surgical Instrument | SIPP, AMY R. | 3775 | §103§112 | Final Rejection | 36d overdue | Pending | Mar 01, 2024 |
| 18251769 | Modular Augment | SHARMA, YASHITA | 3774 | §102§103 | Non-Final OA | 25d overdue | Pending | May 04, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial